HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

admin - April 11, 2025

Latest Pharma-News

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

admin - April 9, 2025

Latest Pharma-News

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

admin - April 9, 2025

Latest Pharma-News

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

admin - April 9, 2025

Latest Pharma-News

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

admin - February 10, 2025

Latest Pharma-News

Hard fought gains in immunization coverage at risk without critical health services, warns WHO

admin - April 23, 2020 0

Latest Pharma-News

Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis...

admin - April 22, 2020 0

Latest Pharma-News

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

admin - April 22, 2020 0

Latest Pharma-News

Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection

admin - April 22, 2020 0

Latest Pharma-News

Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19

admin - April 22, 2020 0

Latest Pharma-News

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients

admin - April 22, 2020 0

Latest Pharma-News

UN agencies issue urgent call to fund the global emergency supply system to fight COVID-19

admin - April 22, 2020 0

Latest Pharma-News

New study to explore the effects of social distancing launched online

admin - April 21, 2020 0

Latest Pharma-News

Five Oxford COVID-19 projects receive UKRI funding

admin - April 21, 2020 0

Latest Pharma-News

Alembic Pharmaceuticals announces USFDA Tentative Approval for Alcaftadine Ophthalmic Solution, 0.25%.

admin - April 21, 2020 1

Latest Pharma-News

Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant...

admin - April 21, 2020 0

Latest Pharma-News

Interim phase 1 data evaluating MOv18 IgE, an anti-folate receptor alpha IgE antibody, in cancer patients with advanced solid tumours to be presented at...

admin - April 21, 2020 0

1...120121122...145 Page 121 of 145

Most Read

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

April 11, 2025

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 9, 2025

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

April 9, 2025

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

April 9, 2025

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved